Komodo Health

Built on one of the largest repositories of real-world patient data in the United States, Komodo Health helps life sciences companies, payers, and health systems turn complex healthcare information into actionable intelligence. Founded in 2014 and headquartered in San Francisco, California, the company has assembled a longitudinal dataset covering hundreds of millions of patient journeys, drawn from claims, electronic health records, and other clinical sources.

The company's flagship platform, the Healthcare Map, sits at the centre of its offering. It models the full continuum of patient experience across disease areas, enabling clients to identify gaps in diagnosis and treatment, understand care pathways, and prioritise commercial or medical strategy with precision. Pharmaceutical manufacturers use Komodo's tools across drug launch planning, real-world evidence generation, patient finding, and competitive intelligence.

Komodo Health serves a broad range of therapy areas including oncology, rare disease, neurology, immunology, and cardiovascular conditions, among others. Its analytics products are used by medical affairs, market access, commercial, and health economics teams within its client base. The company also supports payers and provider organisations seeking to improve population health management through data-driven insights.

Backed by significant venture investment and operating as a private company, Komodo Health has grown rapidly since its founding and counts many of the world's leading pharmaceutical and biotechnology companies among its clients. Its approach of combining breadth of patient-level data with disease-specific analytical frameworks has positioned it as a recognised name in the real-world data and analytics segment of the life sciences industry.

Further information is available at komodohealth.com.